FMR LLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 90 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,468,189
-4.7%
853,598
+8.0%
0.00%
Q2 2023$1,541,116
-65.3%
790,316
-50.5%
0.00%
Q1 2023$4,439,730
+62.8%
1,597,026
+102.0%
0.00%
Q4 2022$2,727,059
+79.2%
790,452
+33.5%
0.00%
Q3 2022$1,522,000
+6.1%
592,210
-0.1%
0.00%
Q2 2022$1,434,000
+149.8%
592,606
+325.4%
0.00%
Q1 2022$574,000
-97.8%
139,304
-93.3%
0.00%
-100.0%
Q4 2021$26,596,000
-19.3%
2,068,151
-32.2%
0.00%
-33.3%
Q3 2021$32,959,000
+29.1%
3,051,858
+9.2%
0.00%
+50.0%
Q2 2021$25,522,000
-4.0%
2,795,413
-0.8%
0.00%0.0%
Q1 2021$26,575,000
+134.9%
2,818,107
-1.8%
0.00%
+100.0%
Q4 2020$11,312,000
+74.9%
2,870,984
+17.7%
0.00%0.0%
Q3 2020$6,466,000
-74.6%
2,439,866
-36.5%
0.00%
-66.7%
Q2 2020$25,498,000
-16.4%
3,840,170
-26.8%
0.00%
-25.0%
Q1 2020$30,516,000
-36.7%
5,243,071
-2.4%
0.00%
-20.0%
Q4 2019$48,177,000
+4.0%
5,370,923
+0.1%
0.01%
-16.7%
Q3 2019$46,335,000
-22.4%
5,366,039
+0.2%
0.01%
-14.3%
Q2 2019$59,686,000
+53.7%
5,357,830
+83.5%
0.01%
+40.0%
Q1 2019$38,827,000
-13.5%
2,919,381
+0.5%
0.01%
-16.7%
Q4 2018$44,864,000
+90.9%
2,903,830
+76.0%
0.01%
+100.0%
Q3 2018$23,496,0001,650,0000.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,102,929$18,059,047,0004.95%
Svennilson Peter 3,102,934$18,059,0002.29%
Casdin Capital, LLC 2,270,000$13,211,0001.40%
FRAZIER MANAGEMENT LLC 2,061,758$11,999,0001.36%
Redmile Group, LLC 3,068,194$17,857,0000.50%
Alphabet Inc. 929,022$5,407,0000.36%
Bleichroeder LP 169,039$984,0000.26%
Leap Investments LP 14,400$84,0000.12%
DAFNA Capital Management LLC 50,000$291,0000.12%
Blackstone Inc. 2,567,445$14,943,0000.11%
View complete list of GRITSTONE ONCOLOGY INC shareholders